Outpatient Parenteral Antimicrobial Therapy Plus Buprenorphine for Opioid Use Disorder and Severe Injection-related Infections.

ABSTRACT: In a pilot randomized trial in persons with opioid use disorder hospitalized with injection-related infections, an innovative care model combining outpatient parenteral antimicrobial therapy with buprenorphine treatment had similar clinical and drug use outcomes to usual care (inpatient intravenous antibiotic completion) and shortened hospital length of stay by 23.5 days.

Clinical trials registration

NCT03048643.

SUBMITTER: Fanucchi LC 

PROVIDER: S-EPMC7931831 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature